We observed that cotreatment with BRI, LAT, or OMD significantly downregulated the mRNA and protein levels of GRP78, which suggested the overall level of ER stress was reduced in tunicamycin-treated human TM cells. This evidence concerns the gene ITM2B and occult macular dystrophy.